Skip to main content

Cardio Diagnostics Hldgs Inc(CDIO-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low1.0900
Day High1.3900
Open:1.0900
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
TheNewswire.com
Cardio Diagnostics Establishes A New Partnership To Facilitate Global Footprint And Expansion Beyond North America With India-Based Aimil Ltd.
TheNewswire.com
With New Lab/Operations Hub, Cardio Diagnostics Says it’s Prepared To Meet Uptake In Demand, Announces New Partner Initiative
TheNewswire.com
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
ACCESSWIRE
Northland Capital Markets Institutional Investor Conference
Business Wire
Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360TM BioPharma Research System
Business Wire
Juniper Research Awards Cardio Diagnostics Holdings, Inc Future Digital Award for Best Digital Diagnostics Solution
Business Wire
Cardio Diagnostics Holdings, Inc to Attend 22nd Annual AHOU Conference
Business Wire
Cardio Diagnostics Holdings, Inc Announces Strategic Engagement with Lifespan.io to Drive Longevity & Heart Disease Research and Education
Business Wire
Cardio Diagnostics Holdings, Inc Sponsors Becker’s Hospital Review 13th Annual Meeting
Business Wire
Cardio Diagnostics Holdings, Inc Announces Financing Agreement with Yorkville Advisors Global, LP of up to $11.2 Million
Business Wire
Cardio Diagnostics Holdings, Inc Welcomes Dr. Damon Broyles, MD, as Strategic Advisor for Precision Cardiovascular Medicine Strategy
Business Wire
Cardio Diagnostics Holdings Inc Announces Expansion of IP Portfolio with Notice of Allowance of Patent Application
Spotlight Growth
Cardio Diagnostics (NASDAQ: CDIO) Unveils Innovative Blood Test to Detect Early Stages of Coronary Heart Disease
Business Wire
Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease
Business Wire
Cardio Diagnostics Holdings Inc to Debut PrecisionCHD™ at the American College of Cardiology’s 72nd Annual Scientific Session
Business Wire
Healing Sanctuary Clinic Partners With Cardio Diagnostics Holdings Inc to Offer the Epi+Gen CHD Test in their Medical Practice in Idaho
Business Wire
Cardio Diagnostics Holdings Inc to Attend 41st Annual JP Morgan Healthcare Conference
Business Wire
Houston Concierge Medicine Partners With Cardio Diagnostics to Offer the Epi+Gen CHD Test in Their Executive Health Program
Business Wire
Cardio Diagnostics to Present at the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
Business Wire
Cardio Diagnostics Named to Fast Company’s Second Annual List of the Next Big Things in Tech
Business Wire
Cardio Diagnostics Holdings Inc Sponsors the Illinois Association of Medicaid Health Plan’s Annual Conference
Business Wire
Cardio Diagnostics Holdings Inc CEO Meesha Dogan, Accepted into Forbes Technology Council
Business Wire
Cardio Diagnostics Holdings Inc Sponsors Becker’s Hospital Review 11th Annual Meeting - The CEO + CFO Roundtable

Profile

Cardio Diagnostics Inc. is a biotechnology company which makes cardiovascular disease prevention and early detection more accessible, personalized and precise. Cardio Diagnostics Inc., formerly known as Mana Capital Acquisition Corp., is based in DOVER, Del.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.